Regulatory22 May 2026, 09:01 pm
Bacil Pharma: Regulation 32 Not Applicable for Quarter Ended March 31, 2026
AI Summary
Bacil Pharma Ltd confirms that Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, concerning the statement of deviation or variation in fund utilization, is not applicable to the company for the quarter ended March 31, 2026. The company clarifies that it did not raise any funds through Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement (QIP), or any other issue during the specified quarter.
Key Highlights
- Regulation 32 of SEBI Regulations not applicable to Bacil Pharma for Q4 2026.
- Bacil Pharma did not raise funds via any public or private issue in Q4 2026.
- The company confirms no deviation or variation in fund utilization.
Price Impact
More from BACPHAR